Anita Sjölander Selected Research

cysteinyl-leukotriene

5/2017	A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
1/2016	Cysteinyl leukotriene 1 receptor influences intestinal polyp incidence in a gender-specific manner in the ApcMin/+ mouse model.
1/2014	Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer.
7/2013	The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells.
7/2011	Cysteinyl leukotriene receptor expression pattern affects migration of breast cancer cells and survival of breast cancer patients.
12/2008	Regulation of the eicosanoid pathway by tumour necrosis factor alpha and leukotriene D4 in intestinal epithelial cells.
10/2007	An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anita Sjölander Research Topics

Disease

31	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2003
30	Neoplasms (Cancer) 01/2022 - 02/2005
15	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2005
9	Inflammation (Inflammations) 05/2017 - 02/2005
5	Adenocarcinoma 05/2017 - 01/2003
4	Carcinogenesis 01/2021 - 02/2005
3	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2013
3	Breast Neoplasms (Breast Cancer) 11/2016 - 11/2005
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2013 - 03/2006
2	Colitis-Associated Neoplasms 08/2020 - 05/2017
2	Blister (Bulla) 01/2020 - 07/2009
2	Polyps 05/2017 - 01/2016
2	Intestinal Polyps 12/2016 - 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2021
1	Colonic Polyps 05/2017
1	Retinal Neovascularization 04/2016
1	Carcinoma (Carcinomatosis) 08/2013
1	Pathologic Processes 12/2010
1	Necrosis 12/2008
1	Retinoblastoma (Glioblastoma, Retinal) 11/2005

Drug/Important Bio-Agent (IBA)

14	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 11/2021 - 01/2003
11	Leukotriene D4IBA 12/2017 - 10/2003
9	LeukotrienesIBA 01/2016 - 01/2003
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2008
7	CateninsIBA 01/2020 - 08/2013
7	EnzymesIBA 05/2017 - 04/2003
7	cysteinyl-leukotrieneIBA 05/2017 - 10/2007
6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 02/2005
6	Messenger RNA (mRNA)IBA 11/2018 - 12/2008
5	15-hydroxyprostaglandin dehydrogenaseIBA 08/2020 - 11/2016
5	Dinoprostone (PGE2)FDA Link 05/2017 - 11/2015
4	Mucin-2IBA 08/2020 - 11/2016
4	cysteinyl leukotriene receptor 2IBA 08/2020 - 10/2007
4	EicosanoidsIBA 01/2016 - 12/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	montelukast (Singulair)FDA Link 01/2020 - 01/2013
3	ProstaglandinsIBA 01/2016 - 01/2003
3	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2016 - 01/2003
3	Leukotriene Receptors (Leukotriene Receptor)IBA 01/2011 - 01/2003
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 11/2021
2	AzoxymethaneIBA 01/2021 - 05/2017
2	Leukotriene C4IBA 08/2020 - 05/2017
2	Caspase 3 (Caspase-3)IBA 01/2020 - 01/2013
2	CytokinesIBA 05/2017 - 10/2013
2	Oligo-1,6-Glucosidase (Isomaltase)IBA 05/2017 - 11/2016
2	LigandsIBA 05/2017 - 11/2016
2	Differentiation AntigensIBA 05/2017 - 11/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2016 - 10/2013
2	LipidsIBA 11/2015 - 12/2010
2	LuciferasesIBA 07/2013 - 01/2011
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2013 - 10/2007
2	IntegrinsIBA 07/2009 - 12/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2003 - 01/2003
1	prostaglandin D2 receptorIBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Estrogen Receptor betaIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021
1	PhosphatidylserinesIBA 01/2021
1	NucleobindinsIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	ERB 041IBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 12/2017
1	Extracellular Matrix ProteinsIBA 12/2017
1	GelatinasesIBA 12/2017
1	Conditioned Culture MediaIBA 12/2017
1	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 05/2017
1	Dextran SulfateIBA 05/2017
1	15-ketoprostaglandin E2IBA 05/2017
1	Hormones (Hormone)IBA 01/2017
1	Chymases (Chymase)IBA 12/2016
1	Sucrose (Saccharose)IBA 11/2016
1	Indicators and Reagents (Reagents)IBA 11/2016
1	Retinaldehyde (Retinal)IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Aldehyde DehydrogenaseIBA 11/2015
1	Cadherins (E-Cadherin)IBA 02/2014
1	Glycogen Synthase (Synthase I)IBA 08/2013
1	Alkaline PhosphataseIBA 07/2013
1	RetinoidsIBA 07/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2013
1	Keratin-18 (Keratin 18)IBA 01/2013
1	CaspasesIBA 01/2013
1	Tamoxifen FDA LinkGeneric 07/2011
1	InterferonsIBA 01/2011
1	Epidermal Growth Factor (EGF)IBA 01/2011
1	CollagenIBA 07/2009
1	Actins (F Actin)IBA 07/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2008
1	leukotriene-C4 synthaseIBA 12/2008
1	Butyrates (Butyrate)IBA 10/2007
1	Arachidonic Acid (Vitamin F)IBA 12/2006
1	Cyclin EIBA 11/2005
1	Protein Kinase CIBA 11/2005

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2014
1	Aftercare (After-Treatment) 05/2017